Why patients go for Aclasta reinfusion? : are they really satisfied with Aclasta or are they compelled to take it ?

Abstract

Novartis International AG is a well known multinational company who is ranking number two in sales among the worldwide Pharmaceutical industry. Now, in the current year 2012, prediction goes that it is going to top Pfizer and take the top rank in global Pharmaceuticals. Novartis (Bangladesh) Limited had started its operation officially in 1997 but the local competition is so enormous that they are not in the top ten rank in Bangladesh. Their slogan is “Care and cure” and by that, they are emphasizing more on the welfare, benefits and safety of the people. Aclasta is one of the special products of Novartis which is prescribed to cure osteoporosis. Osteoporosis is basically a bone loss disease where bone becomes weak and causes fractures afterwards. It is the first original medicine which contains Zoledronic Acid and is known as a revolutionary medical discovery for osteoporosis because of it’s once a year treatment. The infusion of the drug is pretty expensive but it’s effective as well. Among all the projects, Aclasta has been chosen for preparing the internship report because the organization allowed me to disclose the results of this report. One of the answers of research questions that the organization was looking for was whether the patients who are taking Aclasta reinfusion are finding the drug effective or not. They wanted to know the exact reason that whether the patients are taking the reinfusion because they are really satisfied with the outcomes or they are being compelled to take it by the doctors. Due to prices and other factors, Patients may not like to the infusion further. So the research has been done to find out the answer of those questions. For this, a questionnaire has been made and through telephone survey, patients had been asked by the team to give a feedback to those questions. After getting their answers, all the data has been sorted out and through SPSS, analysis has been done. Under one major hypothesis, 17 sub hypotheses has been made and then it was compared with other variables to find out associations and difference. Many methods have been used such as, Chi-Square test, regression, cross tabulations etc. Then after the analysis; the result has been interpreted and it was concluded with some findings and recommendations. Finally, the answer that has been found is that the patients are satisfied with Aclasta reinfusion so they are taking it; they are not being compelled to take it.